Therapeutic options to treat sulfur mustard poisoning-The road ahead

Toxicology

Volumn 263, Issue 1, 2009, Pages 70-73

  Smith, William J ^a  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

Acute injury; HD; Sulfur mustard; Therapeutics; Treatments

Indexed keywords

1 (40 AMINOPHENYL) 3 (4 CHLOROPHENYL)UREA; 2 METHYL 2 MERCAPTOPYRIDINE 1 OXIDE; 3 (4' BROMOPHENYL)UREIDOBENZAMIDE; 6 METHYL 2 MERCAPTOPYRIDINE 1 OXIDE; BENZOYLENE UREA; DEXAMETHASONE; DICLOFENAC; DIMERCAPROL; FLUPHENAZINE; HOMOVANILLIC ACID; HYDROCORTISONE; HYDROGEN PEROXIDE; INDOMETACIN; IODINE; MUSTARD GAS; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; OLVANIL; PROTEINASE INHIBITOR; PYRIDINE DERIVATIVE; PYRITHIONE; UNCLASSIFIED DRUG;

BLISTER; CHEMICAL WARFARE; CYTOTOXICITY; DRUG SCREENING; EYE INJURY; HUMAN; MILITARY RESEARCH; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SKIN INJURY; SKIN PROTECTION; SKIN TOXICITY; WOUND HEALING;

ACUTE DISEASE; ANIMALS; CHEMICAL WARFARE AGENTS; DERMATOLOGIC AGENTS; DISEASE MODELS, ANIMAL; HUMANS; MUSTARD GAS; POISONING; SKIN ABSORPTION; SKIN DISEASES;

EID: 67849115854     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2008.09.012     Document Type: Review

References (13)

1. Amir A., Turetz J., Chapman S., Fishbeine E., Meshulam J., Sahar R., Liani H., Gilat E., Frishman G., and Kadar T. Beneficial effects of topical anti-inflammatory drugs against sulfur mustard-induced ocular lesions in rabbits. J. Appl. Toxicol. 20 (2000) S109-S114
2. Babin M.C., Ricketts K.M., Gazaway M.Y., Lee R.B., Sweeney R.E., and Brozetti J.J. A combination drug treatment against ocular sulfur mustard injury. J. Toxicol.: Cutan. Ocular Toxicol. 23 (2004) 65-75
3. Brodsky B., Erlanger-Rosengarten A., Proscura E., Shapira E., and Wormser U. From topical antidote against skin irritants to a novel counter-irritating and anti-inflammatory peptide. Toxicol. Appl. Pharmacol. 229 (2008) 342-350
4. Casillas R.P., Mitcheltree L.W., and Stemler F.W. The mouse ear model of cutaneous sulfur mustard injury. Toxicol. Methods 7 (1997) 381-397
5. Dachir S., Fishbeine E., Meshulam Y., Sahar R., Amir A., and Kadar T. Potential anti-inflammatory treatments against cutaneous sulfur mustard injury using the mouse ear vesicant model. Hum. Exp. Toxicol. 21 (2002) 197-203
6. Papirmeister B., Feister A.J., Robinson S.I., and Ford R.D. Medical Defense Against Mustard Gas: Toxic Mechanisms and Pharmacological Implications (1991), CRC Press, Boca Raton, FL
7. Rosenthal D.S., Velena A., Chou F.P., Schlegel R., Ray R., Benton B., Anderson D., Smith W.J., and Simbulan-Rosenthal C.M. Expression of dominant-negative FADD blocks human keratinocyte apoptosis and vesication induced by sulfur mustard. J. Biol. Chem. 278 (2003) 8531-8540
8. Smith, W.J., Casillas, R.P., Gross, C.L., Koplovitz, I., 1998. Therapeutic approaches to dermatotoxicity by sulfur mustard. Number 122 in Proceedings of US Army MRMC Bioscience Review, Baltimore, MD, May-June. DTIC AD M001167.
9. Smith W.J., and Dunn M.A. Medical defense against blistering chemical warfare agents. Arch. Dermatol. 127 (1991) 1207-1213
10. Smith, W.J., Martens, M.E., Gross, C.L., Clark, O.E., Cowan, F.C., 1996. Therapeutic approaches to cutaneous injury by sulfur mustard. In: Proceedings of the 20th Army Science Conference, vol. 2, pp. 699-703.
11. Smith W.J., Martens M.E., Gross C.L., Clark O.E., Cowan F.C., and Yourick J.J. The use of in vitro systems to define therapeutic approaches to cutaneous injury by sulfur mustard. In: Salem H., and Katz S.A. (Eds). Toxicity Assessment Alternatives: Methods, Issues, Opportunities (1999), Humana Press, Totowa, NJ 205-212
12. Smith, W.J., Mol, M.A.E., 1997. Progress and future direction of research into the toxicity and treatment of sulfur mustard exposure. NATO Technical Report AC/243 (Panel 8) TR/19.
13. Yourick J.J., Clark C.R., and Mitcheltree L. Niacinamide pretreatment reduces microvesicle formation in hairless guinea pigs cutaneously exposed to sulfur mustard. Fundam. Appl. Toxicol. 17 (1991) 533-542